Nucleoplasmic Mobilization of Nucleostemin Stabilizes MDM2 and Promotes G2-M Progression and Cell Survival

Overview

Journal J Cell Sci

Specialty Cell Biology

Date 2008 Nov 27

PMID 19033382

Citations 38

Authors

Lingjun Meng

Tao Lin

Robert Y L Tsai

Affiliations

Soon will be listed here.

Abstract

Nucleolar disassembly occurs during mitosis and nucleolar stress, releasing several MDM2-interactive proteins residing in the nucleolus that share the common activity of p53 stabilization. Here, we demonstrate that mobilization of nucleostemin, a nucleolar protein enriched in cancer and stem cells, has the opposite role of stabilizing MDM2 and suppressing p53 functions. Our results show that nucleostemin increases the protein stability and nucleoplasmic retention of MDM2, and competes with L23 for MDM2 binding. These activities were significantly elevated when nucleostemin is released into the nucleoplasm by mutations that abolish its nucleolar localization or by chemotherapeutic agents that disassemble the nucleoli. Nucleostemin depletion decreases MDM2 protein, increases transcription activity without affecting the level of p53 protein, and triggers G2-M arrest and cell death in U2OS cells but not in H1299 cells. This work reveals that nucleoplasmic relocation of nucleostemin during nucleolar disassembly safeguards the G2-M transit and survival of continuously dividing cells by MDM2 stabilization and p53 inhibition.

Citing Articles

Transcriptional control of a stem cell factor nucleostemin in liver regeneration and aging.

Liu X, Wang J, Li F, Timchenko N, Tsai R PLoS One. 2024; 19(9):e0310219.

PMID: 39259742 PMC: 11389944. DOI: 10.1371/journal.pone.0310219.

Nucleolar stress: Friend or foe in cardiac function?.

Yan D, Hua L Front Cardiovasc Med. 2022; 9:1045455.

PMID: 36386352 PMC: 9659567. DOI: 10.3389/fcvm.2022.1045455.

Mobility of Nucleostemin in Live Cells Is Specifically Related to Transcription Inhibition by Actinomycin D and GTP-Binding Motif.

Pack C, Jung K, Paulson B, Kim J Int J Mol Sci. 2021; 22(15).

PMID: 34361059 PMC: 8347349. DOI: 10.3390/ijms22158293.

Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 signaling cascade.

Krishnan R, Murugiah M, Lakshmi N, Mahalingam S Mol Biol Cell. 2020; 31(26):2904-2919.

PMID: 33147101 PMC: 7927199. DOI: 10.1091/mbc.E20-04-0267.

Silencing of Nucleostemin by siRNA Induces Apoptosis in MCF-7 and MDA-MB-468 Cell Lines.

Moudi M, Saravani R, Sargazi S Iran J Pharm Res. 2020; 19(1):37-45.

PMID: 32922467 PMC: 7462512. DOI: 10.22037/ijpr.2020.1100950.

References

Dai M, Sun X, Lu H . Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Mol Cell Biol. 2008; 28(13):4365-76. PMC: 2447154. DOI: 10.1128/MCB.01662-07. View

Rubbi C, Milner J . Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus. Oncogene. 2000; 19(1):85-96. DOI: 10.1038/sj.onc.1203378. View

Zhan Q, Antinore M, Wang X, Carrier F, Smith M, Harris C . Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene. 1999; 18(18):2892-900. DOI: 10.1038/sj.onc.1202667. View

Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown J . Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998; 282(5393):1497-501. DOI: 10.1126/science.282.5393.1497. View

Beekman C, Nichane M, De Clercq S, Maetens M, Floss T, Wurst W . Evolutionarily conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development. Mol Cell Biol. 2006; 26(24):9291-301. PMC: 1698517. DOI: 10.1128/MCB.01183-06. View

Oliner J, Pietenpol J, Thiagalingam S, Gyuris J, Kinzler K, Vogelstein B . Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 1993; 362(6423):857-60. DOI: 10.1038/362857a0. View

Dai M, Zeng S, Jin Y, Sun X, David L, Lu H . Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition. Mol Cell Biol. 2004; 24(17):7654-68. PMC: 506971. DOI: 10.1128/MCB.24.17.7654-7668.2004. View

Bernardi R, Scaglioni P, Bergmann S, Horn H, Vousden K, Pandolfi P . PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol. 2004; 6(7):665-72. DOI: 10.1038/ncb1147. View

Zhu Q, Yasumoto H, Tsai R . Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability. Mol Cell Biol. 2006; 26(24):9279-90. PMC: 1698521. DOI: 10.1128/MCB.00724-06. View

10.

Tsai R, McKay R . A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin. J Cell Biol. 2005; 168(2):179-84. PMC: 2171593. DOI: 10.1083/jcb.200409053. View

11.

Haupt Y, Maya R, Kazaz A, Oren M . Mdm2 promotes the rapid degradation of p53. Nature. 1997; 387(6630):296-9. DOI: 10.1038/387296a0. View

12.

Kurki S, Peltonen K, Latonen L, Kiviharju T, Ojala P, Meek D . Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell. 2004; 5(5):465-75. DOI: 10.1016/s1535-6108(04)00110-2. View

13.

Itahana K, Mao H, Jin A, Itahana Y, Clegg H, Lindstrom M . Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell. 2007; 12(4):355-66. DOI: 10.1016/j.ccr.2007.09.007. View

14.

Momand J, Zambetti G, Olson D, George D, Levine A . The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992; 69(7):1237-45. DOI: 10.1016/0092-8674(92)90644-r. View

15.

Jin A, Itahana K, Okeefe K, Zhang Y . Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Mol Cell Biol. 2004; 24(17):7669-80. PMC: 506972. DOI: 10.1128/MCB.24.17.7669-7680.2004. View

16.

Taylor W, Stark G . Regulation of the G2/M transition by p53. Oncogene. 2001; 20(15):1803-15. DOI: 10.1038/sj.onc.1204252. View

17.

Ma H, Pederson T . Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway. Mol Biol Cell. 2007; 18(7):2630-5. PMC: 1924810. DOI: 10.1091/mbc.e07-03-0244. View

18.

Kubbutat M, Jones S, Vousden K . Regulation of p53 stability by Mdm2. Nature. 1997; 387(6630):299-303. DOI: 10.1038/387299a0. View

19.

Meng L, Zhu Q, Tsai R . Nucleolar trafficking of nucleostemin family proteins: common versus protein-specific mechanisms. Mol Cell Biol. 2007; 27(24):8670-82. PMC: 2169394. DOI: 10.1128/MCB.00635-07. View

20.

Zhang Y, White Wolf G, Bhat K, Jin A, Allio T, Burkhart W . Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol. 2003; 23(23):8902-12. PMC: 262682. DOI: 10.1128/MCB.23.23.8902-8912.2003. View